Immunology
Showing page 97 of 176 pages of list content
-
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
This article's authors -
Durability of immune responses to the BNT162b2 mRNA vaccine
This article's authors -
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
This article's authors -
Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants
This article's authors -
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques
This article's authors -
The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity
This article's authors -
ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants
This article's authors -
Inflammasome activation in infected macrophages drives COVID-19 pathology
This article's authors -
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease
This article's authors -
IRAK1-dependent Regnase-1-14-3-3 complex formation controls Regnase-1-mediated mRNA decay
This article's authors